Physician profile
Sean Patrick Whalen
NPI 1124201298
$149,225.16
in general payments reported to CMS, 2019-2025
32 companies · $37K in 2025
The $37K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $9,522 · 2021: $9,103 · 2022: $15K · 2023: $22K · 2024: $24K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Consulting Fee: $16K · Travel and Lodging: $14K · Food and Beverage: $9,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,313.00 |
| Consulting Fee | $16,375.00 |
| Travel and Lodging | $13,942.36 |
| Food and Beverage | $9,389.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $78,173.63 | 2019-2025 | Farapulse, General - Therapies, Watchman Access System |
| Biosense Webster, INC. | $19,859.96 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medtronic, INC. | $12,374.39 | 2021-2025 | Affera Mapping System, Cardioinsight, Pulseselect |
| Atricure, INC. | $8,739.02 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abbott Laboratories | $8,406.09 | 2019-2025 | Amplatzer Amulet, Ensite, Aveir |
| Biotronik INC. | $8,149.53 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Selectra |
| Philips North America LLC | $6,205.95 | 2019-2024 | (9274) Lld |
| Medical Device Business Services, INC. | $5,175.00 | 2020-2021 | |
| Medtronic Vascular, INC. | $275.07 | 2019-2020 | |
| Baylis Medical Company INC | $262.50 | 2021 | |
| Janssen Pharmaceuticals, INC | $259.79 | 2019-2023 | Xarelto |
| Pfizer INC. | $237.88 | 2022-2025 | |
| Edwards Lifesciences Corporation | $186.20 | 2025 | Evoque |
| Altathera Pharmaceuticals LLC | $166.97 | 2023 | Sotalol Hydrochloride |
| Amgen INC. | $92.95 | 2019-2025 | Repatha, Repatha |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $72.30 | 2021-2023 | |
| Ge Healthcare | $69.57 | 2025 | |
| Irhythm Technologies, INC. | $62.71 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Impulse Dynamics (USA) INC. | $59.61 | 2023-2024 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $55.54 | 2019-2025 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.56 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $45.20 | 2022-2023 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $43.38 | 2022-2023 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $38.84 | 2023 | |
| Sanofi-Aventis U.S. LLC | $28.72 | 2019-2021 | |
| Cvrx, INC. | $28.28 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $22.92 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.82 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.52 | 2019 | |
| Vital Connect, INC | $16.44 | 2025 | Vitalpatch Rtm |
| Lexicon Pharmaceuticals, INC. | $15.11 | 2024 | |
| Terumo Medical Corporation | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Whalen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.